Web Results

en.wikipedia.org/wiki/Boston_Scientific

Boston Scientific Corporation (Boston Scientific) is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...

www.bostonscientific.com/en-US/about-us/history.html

Explore Boston Scientific's rich history of delivering meaningful innovation to help doctors improve outcomes and patients live healthier lives.

www.bostonscientific.com/en-US/about-us.html

Learn about who we are, our businesses, our leadership team, our locations and our history.

www.bostonscientific.com/en-US/products/pacemakers/altrua-pacemaker.html

The ALTRUA family of pacemakers deliver the benefits of natural pacing by accurately sensing and responding to the body's signals. AV Search Hysteresis is designed to reduce unnecessary RV pacing without dropping beats, an MV Blended Sensor restores chronotropic competence, and Stored Onset EGMs collect vital ...

www.bostonscientific.com/en-EU/news/newsroom-uk/heart-rhythm-disorder/press-releases-2017/Boston-scientific-launches-RESONATE-family-of-CRT-D-devices-in-europe.html

Feb 6, 2017 ... Feb 06, 2017. Introducing SmartCRT™ technology, providing MultiSite Pacing with up to 13.3 years battery lifei. Boston Scientific Europe today announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT- D) systems in Europe, a new family of devices featuring ...

www.encyclopedia.com/social-sciences-and-law/economics-business-and-labor/businesses-and-occupations/boston-scientific

Boston Scientific went public in May 1992 with an initial public offering (IPO) of 23.5 million shares priced at $17 a share that raised $400 million in capital. Following the IPO, cofounders Nicholas and Abele and their families owned two- thirds of the firm's stock. Nicholas was in charge of the firm's management; Abele had ...

www.prnewswire.com/news-releases/boston-scientific-receives-us-fda-approval-for-resonate-family-of-high-voltage-devices-300453755.html

May 9, 2017 ... MARLBOROUGH, Mass., May 9, 2017 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The approval ...

www.glassdoor.com/Overview/Working-at-Boston-Scientific-EI_IE2187.11,28.htm

See what employees say it's like to work at Boston Scientific. Salaries, reviews, and more - all posted by employees working at Boston Scientific.

seekingalpha.com/article/4059248-boston-scientific-symetis-acquisition

Mar 30, 2017 ... Boston Scientific aims to create a family of cardiovascular valve devices to serve rapidly growing structural heart markets worldwide. Quick Take. Medical technology company Boston Scientific (BSX) has announced an agreement to acquire aortic valve medical device maker Symetis for $435 million in an ...